Current Status of IPR Protection in Russian Pharmaceutical Sector

| By | Drug Patents, Rospatent, Trubor Online
0
487

This video briefly looks at the current status of intellectual property rights protection in Russia’s pharmaceutical sector.

This video covers 3 basic topics:

  • compulsory licensing, taking into account the most recent legislative initiatives and court practice;
  • parallel import (EAEU),
  • patentability criteria.

The parellel import is still a matter of debates. The video reminds that it is based on the trademark rights principle and are currently governed at the level of the Eurasian Econimic Union.

The video also provides some statistics based on the Rospatent open data.

Statistics says that for the last year data, there are approximately 14,628 patents in the pharmaceutical sector. 7897 among them are hold by foreign patent holders, and 6731 are by local patent holders.

SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.